Autopsy report · NCT03802058

Concurrent Nab-P/Carboplatin and Thoracic Radiotherapy in Squamous Cell Lung Cancer

“The study was halted because enrollment was too slow”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 months before it started.
• Ran for about 2 years 9 months before it stopped.
• 24 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Wuhan University

Sponsor type

University, hospital or other

Conditions

Carcinoma, Non-Small-Cell Lung; Squamous Cell Carcinoma

Interventions

Nab-paclitaxel; Carboplatin; Thoracic radiation therapy

Participants

24

Sites

1

Countries

China

Trials that died the same way

• Dabrafenib, Trametinib, and Spartalizumab for the Treatment of BRAF V600E or V600K Mutation Positive Stage IIIB/C/D Melanoma
  “Study stopped due to slow enrollment” (91% match in meaning)
• LCP-Tacro vs. Azathioprine for the Treatment of Autoimmune Hepatitis
  “Study was discontinued due to slow enrollment” (89% match in meaning)
• Intensity Modulated Radiation Therapy (IMRT) for Patients With Rectal Cancer
  “The study was closed to enrollment due to slow accrual.” (88% match in meaning)
• Hand Injected Ventriculography vs. Power Injected Left Ventriculography
  “Study was stopped due to low enrollment.” (87% match in meaning)
• Circumferential Compression STITCH Repairs of Complex and Horizontal Cleavage Meniscal Tears
  “Slow enrollment resulted in the decision to prematurely terminate the study” (87% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.